Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study

Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study

<p>Abstract</p> <p>Background</p> <p>Glatiramer acetate (GA) and interferon-beta (INFb) are first-line disease modifying drugs for relapsing remitting multiple sclerosis (RRMS). Treatment with INFb is associated with a significant increase in health-related quality of l...

Full description

Bibliographic Details
Main Authors: Fredrikson Sten, Seeldrayers Pierette, Sanders Evert, Lehnick Dirk, Jongen Peter J, Andersson Magnus, Speck Joachim
Format: Article
Language:English
Published: BMC 2010-11-01
Series:Health and Quality of Life Outcomes
Online Access:http://www.hqlo.com/content/8/1/133

Internet

http://www.hqlo.com/content/8/1/133

Similar Items